アルツハイマー病向け臨床栄養市場の市場規模、シェア、動向分析レポート：製品別、ステージ別、販売チャネル別、地域別、セグメント別予測、2024年～2030年

アルツハイマー病向け臨床栄養市場の成長と動向：

Grand View Research社の最新レポートによると、アルツハイマー病向け臨床栄養の世界市場規模は2030年までに17億米ドルに達し、予測期間中にCAGR 5.2％で成長すると予測されています。

市場成長の背景には、アルツハイマー病の有病率の増加や、啓発プログラムという形での政府からの支援の増加があります。さらに、アルツハイマー病患者の食事管理に関する研究開発の増加が成長に寄与しています。アルツハイマー病は、著しい認知機能低下を引き起こし、日常生活に支障をきたす慢性疾患です。現在の治療法は認知症の症状を一時的に緩和し、より重篤な段階への進行を遅らせる可能性があるが、アルツハイマー病は依然として米国における死亡原因の第6位を占めています。

アルツハイマー病がヘルスケアシステムに与える経済的影響は大きく、そのコストは数十億米ドルにのぼり、高齢化により2050年までに1兆ドル以上に急増すると予測されています。2030年までに、アルツハイマー型認知症が世界に与える経済的影響は2兆ドルに達すると予想されています。この緊急性を認識している大手企業は、患者のアドヒアランスを高めるため、オーダーメイドの臨床栄養ソリューションを導入しています。このような技術革新の一例として、ダノン・ニュートリシアのSouvenaidが挙げられます。SouvenaidはLipiDiDietプロジェクトの医療用食品で、高用量のオメガ3製剤により早期アルツハイマー病患者の日常機能を改善するよう設計されています。

さらに、COVID-19の大流行は市場に大きな影響を与えました。サプライチェーンの混乱は製品不足と入手の遅れにつながり、閉鎖措置や制限措置は必要不可欠な栄養療法や日常ヘルスケアへの患者のアクセスを制限しました。研究資金や投資に影響を与えた経済的課題にもかかわらず、免疫健康への重点が高まったことで、臨床栄養製品に対する需要が高まった。遠隔医療サービスの採用が急増し、アルツハイマー病患者の栄養指導への継続的なアクセスが可能になった。しかし、臨床試験や研究プロジェクトの遅れが新製品の開発を遅らせた。全体として、パンデミックは慢性疾患の管理における栄養の重要な役割を浮き彫りにし、この分野への今後の注目と投資を後押しする可能性があります。

Danone S.A.（Nutricia）、Pristine Organics、Alfasigma USA, Inc.などの市場の主要企業は、製品の発売、パートナーシップ、事業拡大、提携、M&Aなど様々な戦略を採用しています。こうした戦略的取り組みを通じて、業界各社は自社の地位を強化し、顧客基盤を拡大しようとしています。例えば、2024年5月、ダノンは米国で経管栄養ソリューションを提供するFunctional Formularies社をSwander Pace Capital社から買収しました。この買収はダノンのリニューアル戦略の戦略的要素であり、経腸経管栄養製品のポートフォリオを拡大することで、米国市場における医療栄養製品の提供を強化するものです。

アルツハイマー病向け臨床栄養市場レポートハイライト：

• 市場は製品によって経口、経腸、非経口に区分されます。経口臨床栄養は2023年に49.51%のシェアで市場を独占しました。
• 経口栄養剤に対する需要の高まりは、アルツハイマー症状を軽減できる効果的な経口製剤の開発をメーカーに促しています。
• 非経口臨床栄養セグメントは、2024年から2030年までのCAGRが6.3%で、最も速い成長が見込まれています。
• 市場は病期によって成人と小児に区分されます。
• 成人は2023年の収益シェアで市場を独占し、成人のアルツハイマー病有病率の増加により、予測期間中CAGR 5.3％で最速成長すると推計されます。
• 加えて、この年齢層におけるアルツハイマー病の管理における栄養の役割に関する認識と教育の高まりが、同分野の成長を促進すると予想されます。
• 市場は販売チャネル別にオンライン、小売、施設に区分されます。施設販売チャネルは、アルツハイマー病の治療のために病院による臨床栄養の採用が増加しているため、2023年に46.36％の最大シェアを占めました。
• 北米は2023年に最大のシェアを占めました。この成長は、同地域におけるアルツハイマー病の有病率の増加と市場における著名なプレイヤーの存在に起因しています。
• しかし、アジア太平洋は予測期間中に最も速いCAGRを経験すると予測されています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 アルツハイマー病向け臨床栄養市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/補助市場見通し
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
  • 業界の課題と機会の分析
• アルツハイマー病向け臨床栄養市場分析ツール
  • ポーターの分析
  • PESTEL分析
• COVID-19の影響

第4章 アルツハイマー病向け臨床栄養市場：製品別推定・動向分析

• 定義と範囲
• 製品別市場シェア分析、2023年および2030年
• セグメントダッシュボード
• アルツハイマー病向け臨床栄養市場：製品別、2018～2030年
• 経口
• 経腸
• 非経口

第5章 アルツハイマー病向け臨床栄養市場：ステージ別推定・動向分析

• 定義と範囲
• ステージ別市場シェア分析、2023年および2030年
• セグメントダッシュボード
• アルツハイマー病向け臨床栄養市場：ステージ別、2018～2030年
• 成人
• 小児

第6章 アルツハイマー病向け臨床栄養市場：販売チャネル別推定・動向分析

• 定義と範囲
• 販売チャネル別市場シェア分析、2023年および2030年
• セグメントダッシュボード
• アルツハイマー病向け臨床栄養市場：販売チャネル別、2018～2030年
• オンライン
• 小売り
• 機関

第7章 アルツハイマー病向け臨床栄養市場：国、製品、段階、販売チャネルの地域別推定・動向分析

• 定義と範囲
• 地域別市場シェア分析、2023年および2030年
• 地域別市場ダッシュボード
• 地域別市場のスナップショット
• SWOT分析
• アルツハイマー病向け臨床栄養市場シェア、地域別、2023年および2030年
• 北米
• 欧州
• アジア太平洋
• ラテンアメリカ
• 中東およびアフリカ

第8章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 企業分類
• 企業の市場シェア/ポジション分析、2023年
• 企業ヒートマップ分析
• 戦略マッピング
  • 拡大
  • 合併と買収
  • パートナーシップとコラボレーション
  • 新製品の発売
  • 研究開発
• 企業プロファイル
  • Danone SA（Nutricia）
  • Pristine Organics
  • AlfasigmaUSA, Inc

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviation
• Table 3 North America Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by Product, 2018 - 2030 (USD Million)
• Table 4 North America Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
• Table 5 North America Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by Sales Channel, 2018 - 2030 (USD Million)
• Table 6 U.S. Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by Product, 2018 - 2030 (USD Million)
• Table 7 U.S. Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
• Table 8 U.S. Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by Sales Channel, 2018 - 2030 (USD Million)
• Table 9 Canada Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by Product, 2018 - 2030 (USD Million)
• Table 10 Canada Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
• Table 11 Canada Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by Sales Channel, 2018 - 2030 (USD Million)
• Table 12 Mexico Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by Product, 2018 - 2030 (USD Million)
• Table 13 Mexico Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
• Table 14 Mexico Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by Sales Channel, 2018 - 2030 (USD Million)
• Table 15 Europe Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by Product, 2018 - 2030 (USD Million)
• Table 16 Europe Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
• Table 17 Europe Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by Sales Channel, 2018 - 2030 (USD Million)
• Table 18 UK Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by Product, 2018 - 2030 (USD Million)
• Table 19 UK Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
• Table 20 UK Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by Sales Channel, 2018 - 2030 (USD Million)
• Table 21 Germany Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by Product, 2018 - 2030 (USD Million)
• Table 22 Germany Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
• Table 23 Germany Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by Sales Channel, 2018 - 2030 (USD Million)
• Table 24 France Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by Product, 2018 - 2030 (USD Million)
• Table 25 France Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
• Table 26 France Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by Sales Channel, 2018 - 2030 (USD Million)
• Table 27 Italy Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by Product, 2018 - 2030 (USD Million)
• Table 28 Italy Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
• Table 29 Italy Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by Sales Channel, 2018 - 2030 (USD Million)
• Table 30 Spain Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by Product, 2018 - 2030 (USD Million)
• Table 31 Spain Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
• Table 32 Spain Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by Sales Channel, 2018 - 2030 (USD Million)
• Table 33 Sweden Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by Product, 2018 - 2030 (USD Million)
• Table 34 Sweden Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
• Table 35 Sweden Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by Sales Channel, 2018 - 2030 (USD Million)
• Table 36 Denmark Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by Product, 2018 - 2030 (USD Million)
• Table 37 Denmark Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
• Table 38 Denmark Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by Sales Channel, 2018 - 2030 (USD Million)
• Table 39 Norway Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by Product, 2018 - 2030 (USD Million)
• Table 40 Norway Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
• Table 41 Norway Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by Sales Channel, 2018 - 2030 (USD Million)
• Table 42 Asia Pacific Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by Product, 2018 - 2030 (USD Million)
• Table 43 Asia Pacific Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
• Table 44 Asia Pacific Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by Sales Channel, 2018 - 2030 (USD Million)
• Table 45 Japan Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by Product, 2018 - 2030 (USD Million)
• Table 46 Japan Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
• Table 47 Japan Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by Sales Channel, 2018 - 2030 (USD Million)
• Table 48 China Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by Product, 2018 - 2030 (USD Million)
• Table 49 China Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
• Table 50 China Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by Sales Channel, 2018 - 2030 (USD Million)
• Table 51 India Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by Product, 2018 - 2030 (USD Million)
• Table 52 India Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
• Table 53 India Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by Sales Channel, 2018 - 2030 (USD Million)
• Table 54 Australia Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by Product, 2018 - 2030 (USD Million)
• Table 55 Australia Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
• Table 56 Australia Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by Sales Channel, 2018 - 2030 (USD Million)
• Table 57 South Korea Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by Product, 2018 - 2030 (USD Million)
• Table 58 South Korea Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
• Table 59 South Korea Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by Sales Channel, 2018 - 2030 (USD Million)
• Table 60 Thailand Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by Product, 2018 - 2030 (USD Million)
• Table 61 Thailand Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
• Table 62 Thailand Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by Sales Channel, 2018 - 2030 (USD Million)
• Table 63 Latin America Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by Product, 2018 - 2030 (USD Million)
• Table 64 Latin America Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
• Table 65 Latin America Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by Sales Channel, 2018 - 2030 (USD Million)
• Table 66 Brazil Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by Product, 2018 - 2030 (USD Million)
• Table 67 Brazil Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
• Table 68 Brazil Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by Sales Channel, 2018 - 2030 (USD Million)
• Table 69 Argentina Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by Product, 2018 - 2030 (USD Million)
• Table 70 Argentina Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
• Table 71 Argentina Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by Sales Channel, 2018 - 2030 (USD Million)
• Table 72 MEA Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by Product, 2018 - 2030 (USD Million)
• Table 73 MEA Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
• Table 74 MEA Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by Sales Channel, 2018 - 2030 (USD Million)
• Table 75 South Africa Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by Product, 2018 - 2030 (USD Million)
• Table 76 South Africa Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
• Table 77 Saudi Arabia Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by Product, 2018 - 2030 (USD Million)
• Table 78 Saudi Arabia Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
• Table 79 Saudi Arabia Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by Sales Channel, 2018 - 2030 (USD Million)
• Table 80 UAE Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by Product, 2018 - 2030 (USD Million)
• Table 81 UAE Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
• Table 82 UAE Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by Sales Channel, 2018 - 2030 (USD Million)
• Table 83 Kuwait Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by Product, 2018 - 2030 (USD Million)
• Table 84 Kuwait Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
• Table 85 Kuwait Clinical Nutrition for Alzheimer's Disease Market estimates and forecasts, by Sales Channel, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 List of Figures
• Fig. 2 Clinical Nutrition for Alzheimer's Disease Market Segmentation
• Fig. 3 Information Procurement
• Fig. 4 Data Analysis Models
• Fig. 5 Market Formulation and Validation
• Fig. 6 Data Validating & Publishing
• Fig. 7 Market Snapshot
• Fig. 8 Segment Snapshot (1/2)
• Fig. 9 Segment Snapshot (2/2)
• Fig. 10 Competitive Landscape Snapshot
• Fig. 11 Clinical Nutrition for Alzheimer's Disease Market: Market Dynamics
• Fig. 12 Clinical Nutrition for Alzheimer's Disease Market: PORTER's Analysis
• Fig. 13 Clinical Nutrition for Alzheimer's Disease Market: PESTEL Analysis
• Fig. 14 Clinical Nutrition for Alzheimer's Disease Market Share by Product 2023 & 2030 (USD Million)
• Fig. 15 Clinical Nutrition for Alzheimer's Disease Market, by Product: Market Share, 2023 & 2030
• Fig. 16 Oral Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 17 Enteral Market Estimates & Forecasts, 2018 - 2030 (USD Million)
• Fig. 18 Parenteral Market Estimates & Forecasts, 2018 - 2030 (USD Million)
• Fig. 19 Clinical Nutrition for Alzheimer's Disease Market, by Stage: Key Takeaways
• Fig. 20 Clinical Nutrition for Alzheimer's Disease Market, by Stage: Market Share, 2023 & 2030
• Fig. 21 Adult Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 22 Pediatric Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 23 Clinical Nutrition for Alzheimer's Disease Market Share by Sales Channel 2023 & 2030 (USD Million)
• Fig. 24 Clinical Nutrition for Alzheimer's Disease Market, by Sales Channel: Market Share, 2023 & 2030
• Fig. 25 Online Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Million)
• Fig. 26 Retail Market Estimates & Forecasts, 2018 - 2030 (USD Million)
• Fig. 27 Institutional Market Estimates & Forecasts, 2018 - 2030 (USD Million)
• Fig. 28 Clinical Nutrition for Alzheimer's Disease Market Revenue, by Region, 2023 & 2030 (USD Million)
• Fig. 29 Regional Marketplace: Key Takeaways
• Fig. 30 Regional Marketplace: Key Takeaways
• Fig. 31 North America Clinical Nutrition for Alzheimer's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 32 U.S. Clinical Nutrition for Alzheimer's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 33 Canada Clinical Nutrition for Alzheimer's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 34 Mexico Clinical Nutrition for Alzheimer's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 35 Europe Clinical Nutrition for Alzheimer's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 36 UK Clinical Nutrition for Alzheimer's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 37 Germany Clinical Nutrition for Alzheimer's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 38 France Clinical Nutrition for Alzheimer's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 39 Italy Clinical Nutrition for Alzheimer's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 40 Spain Clinical Nutrition for Alzheimer's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 41 Sweden Clinical Nutrition for Alzheimer's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 42 Denmark Clinical Nutrition for Alzheimer's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 43 Norway Clinical Nutrition for Alzheimer's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 44 Asia Pacific Clinical Nutrition for Alzheimer's Disease Market Estimates and Forecast, 2018 - 2030 (USD Million)
• Fig. 45 Japan Clinical Nutrition for Alzheimer's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 46 China Clinical Nutrition for Alzheimer's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 47 India Clinical Nutrition for Alzheimer's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 48 Australia Clinical Nutrition for Alzheimer's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 49 South Korea Clinical Nutrition for Alzheimer's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 50 Thailand Clinical Nutrition for Alzheimer's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 51 Latin America Clinical Nutrition for Alzheimer's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 52 Brazil Clinical Nutrition for Alzheimer's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 53 Argentina Clinical Nutrition for Alzheimer's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 54 MEA Clinical Nutrition for Alzheimer's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 55 Saudi Arabia Clinical Nutrition for Alzheimer's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 56 South Africa Clinical Nutrition for Alzheimer's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 57 UAE Clinical Nutrition for Alzheimer's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 58 Kuwait Clinical Nutrition for Alzheimer's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 59 Key Company Categorization
• Fig. 60 Company Market Positioning
• Fig. 61 Key Company Market Share Analysis, 2023
• Fig. 62 Strategic Framework

Clinical Nutrition For Alzheimer's Disease Market Growth & Trends:

The global clinical nutrition for alzheimer's disease market size is expected to reach USD 1.7 billion by 2030, growing at a CAGR of 5.2% over the forecast period, according to a new report by Grand View Research, Inc. The market growth can be attributed to the increasing prevalence of Alzheimer's and growing support from the government in the form of awareness programs. Moreover, growing R&D for dietary management of Alzheimer's patients contributes to growth. Alzheimer's disease is a chronic condition that leads to significant cognitive decline, impairing daily functions. Although current treatments can temporarily alleviate dementia symptoms and potentially decelerate the progression into more severe stages, Alzheimer's remains the sixth-leading cause of mortality in the U.S.

The financial implications of Alzheimer's on the healthcare system are significant, with costs amounting to billions of dollars and forecasts indicating a surge to over USD 1 trillion by 2050 due to an aging population. By 2030, the global economic impact of Alzheimer's dementia is expected to reach USD 2 trillion. Recognizing the urgency, leading players are introducing tailored clinical nutrition solutions to enhance patient adherence. An example of such innovation is Danone Nutricia's Souvenaid, a medical food product under the LipiDiDiet project, designed to improve daily functioning in early-stage Alzheimer's patients through a high-dose omega-3 formulation.

Moreover, the COVID-19 pandemic has significantly impacted the market. Supply chain disruptions led to shortages and delays in product availability, while lockdowns and restrictions limited patient access to essential nutrition therapies and routine healthcare. The increased emphasis on immune health heightened the demand for clinical nutrition products, despite economic challenges that affected funding and investment in research. The adoption of telehealth services surged, enabling continued access to nutritional guidance for Alzheimer's patients. However, delays in clinical trials and research projects slowed the development of new products. Overall, the pandemic underscored the vital role of nutrition in managing chronic diseases, potentially boosting future focus and investment in this field.

Some key players in the market, such as Danone S.A. (Nutricia), Pristine Organics, Alfasigma USA, Inc., are adopting various strategies such as product launches, partnerships, expansions, collaborations, and mergers & acquisitions. Through these strategic initiatives, industry players are trying to strengthen their positions and expand their customer base. For instance, in May 2024, Danone acquired Functional Formularies, a provider of whole food tube feeding solutions in the U.S., from Swander Pace Capital. This acquisition is a strategic component of Danone's Renew Strategy, enhancing the company's medical nutrition offerings in the U.S. market by broadening its portfolio of enteral tube feeding products

Clinical Nutrition For Alzheimer's Disease Market Report Highlights:

• The market is segmented into oral, enteral, and parenteral based on product. Oral clinical nutrition dominated the market with a share of 49.51% in 2023.
• The increasing demand for oral nutrition is encouraging manufacturers to develop effective oral formulas capable of reducing Alzheimer's symptoms.
• The parenteral clinical nutrition segment is anticipated to witness the fastest growth at a CAGR of 6.3% from 2024 to 2030.
• The market is segmented into adults and pediatrics based on stage.
• The adults segment dominated the market in terms of revenue share in 2023 and is estimated to grow at the fastest CAGR of 5.3% over the forecast period, owing to the increasing prevalence of Alzheimer's among adults.
• In addition, the growing awareness and education about the role of nutrition in managing Alzheimer's disease among this age group is expected to drive segment growth.
• The market is segmented by sales channel into online, retail, and institutional. The institutional sales channel held the largest share of 46.36% in 2023, owing to the rising adoption of clinical nutrition by hospitals for the treatment of Alzheimer's disease.
• North America accounted for the largest share in 2023. This growth can be attributed to the increasing prevalence of Alzheimer's disease in the region and the presence of prominent players in the market.
• However, Asia Pacific is anticipated to experience the fastest CAGR during the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
• 1.5. Details of primary research
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.1.1. Approach 1: Commodity flow approach
• 1.8. Research Scope and Assumptions
  • 1.8.1. List of Secondary Sources
  • 1.8.2. List of Primary Sources
  • 1.8.3. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product Outlook
  • 2.2.2. Stage Outlook
  • 2.2.3. Sales Channel Outlook
• 2.3. Competitive Insights

Chapter 3. Clinical Nutrition for Alzheimer's Disease Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Drivers Analysis
  • 3.2.2. Market Restraints Analysis
  • 3.2.3. Industry Challenges and Opportunity Analysis
• 3.3. Clinical Nutrition for Alzheimer's Disease Market Analysis Tools
  • 3.3.1. Porter's Analysis
    • 3.3.1.1. Bargaining power of the suppliers
    • 3.3.1.2. Bargaining power of the buyers
    • 3.3.1.3. Threats of substitution
    • 3.3.1.4. Threats from new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic and Social landscape
    • 3.3.2.3. Technological landscape
    • 3.3.2.4. Environmental landscape
    • 3.3.2.5. Legal landscape
• 3.4. Impact of COVID-19

Chapter 4. Clinical Nutrition for Alzheimer's Disease Market: Product Estimates & Trend Analysis

• 4.1. Definition and Scope
• 4.2. Product Market Share Analysis, 2023 & 2030
• 4.3. Segment Dashboard
• 4.4. Clinical Nutrition for Alzheimer's Disease Market: By Product, 2018 to 2030
• 4.5. Oral
  • 4.5.1. Oral Market Revenue Estimates and Forecasts, 2018 - 2030
• 4.6. Enteral
  • 4.6.1. Enteral Market Revenue Estimates and Forecasts, 2018 - 2030
• 4.7. Parenteral
  • 4.7.1. Parenteral Market Revenue Estimates and Forecasts, 2018 - 2030

Chapter 5. Clinical Nutrition for Alzheimer's Disease Market: Stage Estimates & Trend Analysis

• 5.1. Definition and Scope
• 5.2. Stage Market Share Analysis, 2023 & 2030
• 5.3. Segment Dashboard
• 5.4. Clinical Nutrition for Alzheimer's Disease Market: By Stage, 2018 to 2030
• 5.5. Adult
  • 5.5.1. Adult Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 5.6. Pediatric
  • 5.6.1. Pediatric Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 6. Clinical Nutrition for Alzheimer's Disease Market: Sales Channel Estimates & Trend Analysis

• 6.1. Definition and Scope
• 6.2. Sales Channel Market Share Analysis, 2023 & 2030
• 6.3. Segment Dashboard
• 6.4. Clinical Nutrition for Alzheimer's Disease Market: By Sales Channel, 2018 to 2030
• 6.5. Online
  • 6.5.1. Online Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 6.6. Retail
  • 6.6.1. Retail Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 6.7. Institutional
  • 6.7.1. Institutional Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 7. Clinical Nutrition for Alzheimer's Disease Market: Regional Estimates & Trend Analysis by Country, Product, Stage, Sales Channel

• 7.1. Definition and Scope
• 7.2. Regional Market Share Analysis, 2023 & 2030
• 7.3. Regional Market Dashboard
• 7.4. Regional Market Snapshot
• 7.5. SWOT Analysis
  • 7.5.1. North America
  • 7.5.2. Europe
  • 7.5.3. Asia Pacific
  • 7.5.4. Latin America
  • 7.5.5. Middle East & Africa
• 7.6. Clinical Nutrition for Alzheimer's Disease Market Share, By Region, 2023 & 2030 (USD Million)
• 7.7. North America
  • 7.7.1. North America Clinical Nutrition for Alzheimer's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.2. U.S.
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Regulatory Landscape
    • 7.7.2.3. Competitive Insights
    • 7.7.2.4. U.S. Clinical Nutrition for Alzheimer's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.3. Canada
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Regulatory Landscape
    • 7.7.3.3. Competitive Insights
    • 7.7.3.4. Canada Clinical Nutrition for Alzheimer's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.4. Mexico
    • 7.7.4.1. Key Country Dynamics
    • 7.7.4.2. Regulatory Landscape
    • 7.7.4.3. Competitive Insights
    • 7.7.4.4. Canada Clinical Nutrition for Alzheimer's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.8. Europe
  • 7.8.1. Europe Clinical Nutrition for Alzheimer's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.2. UK
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Regulatory Landscape
    • 7.8.2.3. Competitive Insights
    • 7.8.2.4. U.K. Clinical Nutrition for Alzheimer's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.3. Germany
    • 7.8.3.1. Key Country Dynamics
    • 7.8.3.2. Regulatory Landscape
    • 7.8.3.3. Competitive Insights
    • 7.8.3.4. Germany Clinical Nutrition for Alzheimer's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.4. France
    • 7.8.4.1. Key Country Dynamics
    • 7.8.4.2. Regulatory Landscape
    • 7.8.4.3. Competitive Insights
    • 7.8.4.4. France Clinical Nutrition for Alzheimer's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.5. Italy
    • 7.8.5.1. Key Country Dynamics
    • 7.8.5.2. Regulatory Landscape
    • 7.8.5.3. Competitive Insights
    • 7.8.5.4. Italy Clinical Nutrition for Alzheimer's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.6. Spain
    • 7.8.6.1. Key Country Dynamics
    • 7.8.6.2. Regulatory Landscape
    • 7.8.6.3. Competitive Insights
    • 7.8.6.4. Spain Clinical Nutrition for Alzheimer's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.7. Sweden
    • 7.8.7.1. Key Country Dynamics
    • 7.8.7.2. Regulatory Landscape
    • 7.8.7.3. Competitive Insights
    • 7.8.7.4. Sweden Clinical Nutrition for Alzheimer's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.8. Denmark
    • 7.8.8.1. Key Country Dynamics
    • 7.8.8.2. Regulatory Landscape
    • 7.8.8.3. Competitive Insights
    • 7.8.8.4. Denmark Clinical Nutrition for Alzheimer's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.9. Norway
    • 7.8.9.1. Key Country Dynamics
    • 7.8.9.2. Regulatory Landscape
    • 7.8.9.3. Competitive Insights
    • 7.8.9.4. Norway Clinical Nutrition for Alzheimer's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.9. Asia Pacific
  • 7.9.1. Asia Pacific Clinical Nutrition for Alzheimer's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.9.2. Japan
    • 7.9.2.1. Key Country Dynamics
    • 7.9.2.2. Regulatory Landscape
    • 7.9.2.3. Competitive Insights
    • 7.9.2.4. Japan Clinical Nutrition for Alzheimer's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.9.3. China
    • 7.9.3.1. Key Country Dynamics
    • 7.9.3.2. Regulatory Landscape
    • 7.9.3.3. Competitive Insights
    • 7.9.3.4. China Clinical Nutrition for Alzheimer's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.9.4. India
    • 7.9.4.1. Key Country Dynamics
    • 7.9.4.2. Regulatory Landscape
    • 7.9.4.3. Competitive Insights
    • 7.9.4.4. India Clinical Nutrition for Alzheimer's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.9.5. Australia
    • 7.9.5.1. Key Country Dynamics
    • 7.9.5.2. Regulatory Landscape
    • 7.9.5.3. Competitive Insights
    • 7.9.5.4. Australia Clinical Nutrition for Alzheimer's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.9.6. South Korea
    • 7.9.6.1. Key Country Dynamics
    • 7.9.6.2. Regulatory Landscape
    • 7.9.6.3. Competitive Insights
    • 7.9.6.4. South Korea Clinical Nutrition for Alzheimer's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.9.7. Thailand
    • 7.9.7.1. Key Country Dynamics
    • 7.9.7.2. Regulatory Landscape
    • 7.9.7.3. Competitive Insights
    • 7.9.7.4. Thailand Clinical Nutrition for Alzheimer's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.10. Latin America
  • 7.10.1. Latin America Clinical Nutrition for Alzheimer's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.10.2. Brazil
    • 7.10.2.1. Key Country Dynamics
    • 7.10.2.2. Regulatory Landscape
    • 7.10.2.3. Competitive Insights
    • 7.10.2.4. Brazil Clinical Nutrition for Alzheimer's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.10.3. Argentina
    • 7.10.3.1. Key Country Dynamics
    • 7.10.3.2. Regulatory Landscape
    • 7.10.3.3. Competitive Insights
    • 7.10.3.4. Argentina Clinical Nutrition for Alzheimer's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.11. Middle East and Africa
  • 7.11.1. Middle East and Africa Clinical Nutrition for Alzheimer's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.11.2. South Africa
    • 7.11.2.1. Key Country Dynamics
    • 7.11.2.2. Regulatory Landscape
    • 7.11.2.3. Competitive Insights
    • 7.11.2.4. South Africa Clinical Nutrition for Alzheimer's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.11.3. Saudi Arabia
    • 7.11.3.1. Key Country Dynamics
    • 7.11.3.2. Regulatory Landscape
    • 7.11.3.3. Competitive Insights
    • 7.11.3.4. Saudi Arabia Clinical Nutrition for Alzheimer's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.11.4. UAE
    • 7.11.4.1. Key Country Dynamics
    • 7.11.4.2. Regulatory Landscape
    • 7.11.4.3. Competitive Insights
    • 7.11.4.4. UAE Clinical Nutrition for Alzheimer's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.11.5. Kuwait
    • 7.11.5.1. Key Country Dynamics
    • 7.11.5.2. Regulatory Landscape
    • 7.11.5.3. Competitive Insights
    • 7.11.5.4. Kuwait Clinical Nutrition for Alzheimer's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis by Key Market Participants
• 8.2. Company Categorization
• 8.3. Company Market Share/Position Analysis, 2023
• 8.4. Company Heat Map Analysis
• 8.5. Strategy Mapping
  • 8.5.1. Expansion
  • 8.5.2. Mergers & Acquisition
  • 8.5.3. Partnerships & Collaborations
  • 8.5.4. New Product Launches
  • 8.5.5. Research And Development
• 8.6. Company Profiles
  • 8.6.1. Danone S.A. (Nutricia)
    • 8.6.1.1. Company Overview
    • 8.6.1.2. Financial Performance
    • 8.6.1.3. Product Benchmarking
    • 8.6.1.4. Strategic initiatives
  • 8.6.2. Pristine Organics
    • 8.6.2.1. Company Overview
    • 8.6.2.2. Financial Performance
    • 8.6.2.3. Product Benchmarking
    • 8.6.2.4. Strategic initiatives
  • 8.6.3. AlfasigmaUSA, Inc
    • 8.6.3.1. Company Overview
    • 8.6.3.2. Financial Performance
    • 8.6.3.3. Product Benchmarking
    • 8.6.3.4. Strategic initiatives